Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sujata Patil

Showing results (161-170 of 230) with videos related to

Pageof 23
Sort By:
Clinical Genitourinary Cancer|June 15, 2015
Phase I/II Trial of Paclitaxel With Ifosfamide Followed by High-Dose Paclitaxel, Ifosfamide, and Carboplatin (TI-TIC) With Autologous Stem Cell Reinfusion for Salvage Treatment of Germ Cell TumorsDarren R Feldman, Ilya Glezerman, Sujata Patil, et al.
Diseases of the Colon and Rectum|January 9, 2008
Squamous-cell carcinoma of the anal canal: predictors of treatment outcomeRamin Roohipour, Sujata Patil, Karyn A Goodman, et al.
Cancer|September 16, 2023
Ototoxicity associated with high-dose carboplatin for patients with previously treated germ cell tumorsSamuel A Funt, Andrea Knezevic, Kaamilah Wilson, et al.
Annals of Surgical Oncology|March 30, 2016
KRAS and Combined KRAS/TP53 Mutations in Locally Advanced Rectal Cancer are Independently Associated with Decreased Response to Neoadjuvant TherapyOliver S Chow, Deborah Kuk, Metin Keskin, et al.
Annals of Surgical Oncology|December 11, 2019
Microscopic Extracapsular Extension in Sentinel Lymph Nodes Does Not Mandate Axillary Dissection in Z0011-Eligible PatientsAndrea V Barrio, Stephanie Downs-Canner, Marcia Edelweiss, et al.
NPJ Breast Cancer|October 18, 2024
Predictors of response to CDK4/6i retrial after prior CDK4/6i failure in ER+ metastatic breast cancerNicholas Mai, Carlos H Dos Anjos, Pedram Razavi, et al.
Cancer|April 21, 2012
Standardized uptake value by positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancerPatrick G Morris, Gary A Ulaner, Anne Eaton, et al.
Iscience|February 9, 2024
Preoperative immune checkpoint inhibition and cryoablation in early-stage breast cancerElizabeth Comen, Sadna Budhu, Yuval Elhanati, et al.
The American Journal of Surgical Pathology|June 11, 2021
PD-L1 Expression in Metaplastic Breast Carcinoma Using the PD-L1 SP142 Assay and Concordance Among PD-L1 Immunohistochemical AssaysAnne Grabenstetter, Achim A Jungbluth, Denise Frosina, et al.
Research Square|May 15, 2024
Predictors of Response to CDK4/6i Retrial After Prior CDK4/6i Failure in ER+ Metastatic Breast CancerNicholas Mai, Carlos H Dos Anjos, Pedram Razavi, et al.
Pageof 23

Showing results (161-170 of 230) with videos related to

Sort By:
Pageof 23
Clinical Genitourinary Cancer|June 15, 2015
Phase I/II Trial of Paclitaxel With Ifosfamide Followed by High-Dose Paclitaxel, Ifosfamide, and Carboplatin (TI-TIC) With Autologous Stem Cell Reinfusion for Salvage Treatment of Germ Cell TumorsDarren R Feldman, Ilya Glezerman, Sujata Patil, et al.
Diseases of the Colon and Rectum|January 9, 2008
Squamous-cell carcinoma of the anal canal: predictors of treatment outcomeRamin Roohipour, Sujata Patil, Karyn A Goodman, et al.
Cancer|September 16, 2023
Ototoxicity associated with high-dose carboplatin for patients with previously treated germ cell tumorsSamuel A Funt, Andrea Knezevic, Kaamilah Wilson, et al.
Annals of Surgical Oncology|March 30, 2016
KRAS and Combined KRAS/TP53 Mutations in Locally Advanced Rectal Cancer are Independently Associated with Decreased Response to Neoadjuvant TherapyOliver S Chow, Deborah Kuk, Metin Keskin, et al.
Annals of Surgical Oncology|December 11, 2019
Microscopic Extracapsular Extension in Sentinel Lymph Nodes Does Not Mandate Axillary Dissection in Z0011-Eligible PatientsAndrea V Barrio, Stephanie Downs-Canner, Marcia Edelweiss, et al.
NPJ Breast Cancer|October 18, 2024
Predictors of response to CDK4/6i retrial after prior CDK4/6i failure in ER+ metastatic breast cancerNicholas Mai, Carlos H Dos Anjos, Pedram Razavi, et al.
Cancer|April 21, 2012
Standardized uptake value by positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancerPatrick G Morris, Gary A Ulaner, Anne Eaton, et al.
Iscience|February 9, 2024
Preoperative immune checkpoint inhibition and cryoablation in early-stage breast cancerElizabeth Comen, Sadna Budhu, Yuval Elhanati, et al.
The American Journal of Surgical Pathology|June 11, 2021
PD-L1 Expression in Metaplastic Breast Carcinoma Using the PD-L1 SP142 Assay and Concordance Among PD-L1 Immunohistochemical AssaysAnne Grabenstetter, Achim A Jungbluth, Denise Frosina, et al.
Research Square|May 15, 2024
Predictors of Response to CDK4/6i Retrial After Prior CDK4/6i Failure in ER+ Metastatic Breast CancerNicholas Mai, Carlos H Dos Anjos, Pedram Razavi, et al.
Pageof 23